• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rg3 可防止癌基因长非编码 RNA ATXN8OS 抑制乳腺癌细胞中的抑瘤 microRNA-424-5p。

Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells.

机构信息

Department of Life Science, Dongguk University-Seoul, Goyang 10326, Korea.

出版信息

Biomolecules. 2021 Jan 18;11(1):118. doi: 10.3390/biom11010118.

DOI:10.3390/biom11010118
PMID:33477683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831931/
Abstract

Ginsenoside Rg3 exerts antiproliferation activity on cancer cells by regulating diverse noncoding RNAs. However, little is known about the role of long noncoding RNAs (lncRNAs) or their relationship with competitive endogenous RNA (ceRNA) in Rg3-treated cancer cells. Here, a lncRNA (ATXN8OS) was found to be downregulated via Rg3-mediated promoter hypermethylation in MCF-7 breast cancer cells. SiRNA-induced downregulation of ATXN8OS decreased cell proliferation but increased apoptosis, suggesting that the noncoding RNA possessed proproliferation activity. An in silico search for potential ATXN8OS-targeting microRNAs (miRs) identified a promising candidate (miR-424-5p) based on its high binding score. As expected, miR-424-5p suppressed proliferation and stimulated apoptosis of the MCF-7 cells. The in silico miR-target-gene prediction identified 200 potential target genes of miR-424-5p, which were subsequently narrowed down to seven that underwent hypermethylation at their promoter by Rg3. Among them, three genes (EYA1, DACH1, and CHRM3) were previously known oncogenes and were proven to be oppositely regulated by ATXN8OS and miR-424-5p. When taken together, Rg3 downregulated ATXN8OS that inhibited the tumor-suppressive miR-424-5p, leading to the downregulation of the oncogenic target genes.

摘要

人参皂苷 Rg3 通过调节多种非编码 RNA 对癌细胞发挥抗增殖活性。然而,关于长非编码 RNA (lncRNA)或它们与竞争内源性 RNA (ceRNA)在 Rg3 处理的癌细胞中的关系知之甚少。在这里,发现在 MCF-7 乳腺癌细胞中,通过 Rg3 介导的启动子超甲基化导致 lncRNA (ATXN8OS)下调。ATXN8OS 的 siRNA 诱导下调降低了细胞增殖,但增加了细胞凋亡,表明该非编码 RNA 具有促增殖活性。对潜在的 ATXN8OS 靶向 microRNAs (miRs) 的计算搜索根据其高结合评分确定了一个有前途的候选物(miR-424-5p)。正如预期的那样,miR-424-5p 抑制 MCF-7 细胞的增殖并刺激细胞凋亡。miR 靶基因预测的计算表明,miR-424-5p 的 200 个潜在靶基因随后被 Rg3 下调其启动子的甲基化。其中,三个基因(EYA1、DACH1 和 CHRM3)是先前已知的癌基因,被证明受 ATXN8OS 和 miR-424-5p 的反向调节。总的来说,Rg3 下调了抑制肿瘤抑制性 miR-424-5p 的 ATXN8OS,导致致癌靶基因下调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/6b2d78cabf1f/biomolecules-11-00118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/9fa97ca124e8/biomolecules-11-00118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/087c6192bb0c/biomolecules-11-00118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/a032becb1ed1/biomolecules-11-00118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/0d47d6d5e866/biomolecules-11-00118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/26cccd88d1a7/biomolecules-11-00118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/6b2d78cabf1f/biomolecules-11-00118-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/9fa97ca124e8/biomolecules-11-00118-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/087c6192bb0c/biomolecules-11-00118-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/a032becb1ed1/biomolecules-11-00118-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/0d47d6d5e866/biomolecules-11-00118-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/26cccd88d1a7/biomolecules-11-00118-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf1/7831931/6b2d78cabf1f/biomolecules-11-00118-g006.jpg

相似文献

1
Ginsenoside Rg3 Prevents Oncogenic Long Noncoding RNA ATXN8OS from Inhibiting Tumor-Suppressive microRNA-424-5p in Breast Cancer Cells.人参皂苷 Rg3 可防止癌基因长非编码 RNA ATXN8OS 抑制乳腺癌细胞中的抑瘤 microRNA-424-5p。
Biomolecules. 2021 Jan 18;11(1):118. doi: 10.3390/biom11010118.
2
Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.人参皂苷20(S)-Rg3阻止靶向PKM2的miR-324-5p被H19吸附,以拮抗卵巢癌细胞中的瓦伯格效应。
Cell Physiol Biochem. 2018;51(3):1340-1353. doi: 10.1159/000495552. Epub 2018 Nov 27.
3
Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells.人参皂苷 Rh2 通过调控 CFAP20DC-AS1/miR-3614-3p/BBX 和 TNFAIP3 轴诱导乳腺癌细胞凋亡。
Am J Chin Med. 2022;50(6):1703-1717. doi: 10.1142/S0192415X22500720. Epub 2022 Jul 4.
4
Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.长链非编码 RNA LINC01234 通过 microRNA-193a-5p 介导的 CCNE1 下调在食管癌细胞中发挥抑癌作用。
Cell Oncol (Dordr). 2020 Jun;43(3):377-394. doi: 10.1007/s13402-019-00493-5. Epub 2020 Mar 4.
5
Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.人参皂苷20(S)-Rg3通过调控DNMT3A/miR-532-3p/HK2通路抑制卵巢癌细胞的瓦伯格效应。
Cell Physiol Biochem. 2018;45(6):2548-2559. doi: 10.1159/000488273. Epub 2018 Mar 16.
6
Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67-AS1.人参皂苷 Rh2 通过表观遗传调控长链非编码 RNA C3orf67-AS1 抑制乳腺癌细胞增殖。
Am J Chin Med. 2019;47(7):1643-1658. doi: 10.1142/S0192415X19500848. Epub 2019 Oct 23.
7
Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.长链非编码 RNA 00641 通过海绵吸附 miR-194-5p 抑制乳腺癌细胞增殖、迁移和侵袭。
J Cell Physiol. 2020 Mar;235(3):2668-2675. doi: 10.1002/jcp.29170. Epub 2019 Sep 6.
8
Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.人参皂苷 20(S)-Rg3 通过上调 HIF-1α 靶向 miR-519a-5p 抑制卵巢癌细胞的瓦博格效应。
Clin Exp Pharmacol Physiol. 2020 Aug;47(8):1455-1463. doi: 10.1111/1440-1681.13321. Epub 2020 May 4.
9
HOXC13-AS promotes breast cancer cell growth through regulating miR-497-5p/PTEN axis.HOXC13-AS 通过调控 miR-497-5p/PTEN 轴促进乳腺癌细胞生长。
J Cell Physiol. 2019 Dec;234(12):22343-22351. doi: 10.1002/jcp.28800. Epub 2019 May 8.
10
Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.研究孕激素通过调控长链非编码 RNA NEAT1/微小 RNA-146b-5p 介导的 Wnt/β-连环蛋白信号通路抑制子宫内膜癌细胞周期和活力的机制。
IUBMB Life. 2019 Feb;71(2):223-234. doi: 10.1002/iub.1959. Epub 2018 Nov 19.

引用本文的文献

1
Natural anti-cancer products: insights from herbal medicine.天然抗癌产品:来自草药医学的见解。
Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y.
2
Human disease-related long noncoding RNAs: Impact of ginsenosides.人类疾病相关的长链非编码RNA:人参皂苷的影响
J Ginseng Res. 2024 Jul;48(4):347-353. doi: 10.1016/j.jgr.2024.04.002. Epub 2024 Apr 14.
3
Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review).揭示人参皂苷Rg3抗癌潜力的实验证据(综述)。

本文引用的文献

1
Long Intergenic Non-Coding RNA LINC00922 Aggravates the Malignant Phenotype of Breast Cancer by Regulating the microRNA-424-5p/BDNF Axis.长链基因间非编码RNA LINC00922通过调控微小RNA-424-5p/脑源性神经营养因子轴加重乳腺癌的恶性表型。
Cancer Manag Res. 2020 Aug 21;12:7539-7552. doi: 10.2147/CMAR.S267665. eCollection 2020.
2
LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.长链非编码RNA CDKN2B-AS1通过海绵化miR-424-5p促进肝细胞癌的细胞活力、迁移和侵袭。
Cancer Manag Res. 2020 Aug 4;12:6807-6819. doi: 10.2147/CMAR.S240000. eCollection 2020.
3
Oncol Lett. 2024 Feb 28;27(4):182. doi: 10.3892/ol.2024.14315. eCollection 2024 Apr.
4
Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications.人参皂苷 Rg3:抗癌机制及其潜在治疗应用的综述。
Curr Top Med Chem. 2024;24(10):869-884. doi: 10.2174/0115680266283661240226052054.
5
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.更新人参皂苷在乳腺癌治疗中的作用:从文献计量学研究到深入综述
Front Pharmacol. 2023 Sep 25;14:1226629. doi: 10.3389/fphar.2023.1226629. eCollection 2023.
6
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.人参皂苷:改变癌细胞的基本特征以达到治疗乳腺癌的目的。
Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9.
7
Role of miR-424 in the carcinogenesis.miR-424 在癌症发生中的作用。
Clin Transl Oncol. 2024 Jan;26(1):16-38. doi: 10.1007/s12094-023-03209-2. Epub 2023 May 13.
8
Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications.甲基化与非编码 RNA 在乳腺癌中的相互作用:治疗和诊断意义。
Int J Mol Sci. 2022 Dec 12;23(24):15759. doi: 10.3390/ijms232415759.
9
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer.人参皂苷对乳腺癌的抗癌作用及潜在的微小RNA靶点
Front Pharmacol. 2022 Oct 5;13:1033017. doi: 10.3389/fphar.2022.1033017. eCollection 2022.
10
Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells. Ginsenoside Rh3 对 HCT116 结肠癌细胞增殖抑制作用的转录组分析。
Molecules. 2022 Aug 6;27(15):5002. doi: 10.3390/molecules27155002.
Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
miR-424-5p 通过靶向 PD-L1 并调节 PTEN/PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞中的肿瘤发生活性。
Life Sci. 2020 Oct 15;259:118239. doi: 10.1016/j.lfs.2020.118239. Epub 2020 Aug 10.
4
Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/-Catenin and EMT Signaling Pathway.人参皂苷Rg3通过Wnt/β-连环蛋白和上皮-间质转化信号通路抑制骨肉瘤生长并减弱其转移。
Evid Based Complement Alternat Med. 2020 Jul 11;2020:6065124. doi: 10.1155/2020/6065124. eCollection 2020.
5
Advances on hormone-like activity of Panax ginseng and ginsenosides.人参及人参皂苷的类激素样作用研究进展。
Chin J Nat Med. 2020 Jul;18(7):526-535. doi: 10.1016/S1875-5364(20)30063-7.
6
Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma.褪黑素通过 miR-424-5p/VEGFA 信号通路调节骨肉瘤中的肿瘤血管生成。
Life Sci. 2020 Sep 1;256:118011. doi: 10.1016/j.lfs.2020.118011. Epub 2020 Jun 24.
7
Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.类器官模型表明 DACH1 通过调节 BMP 信号通路在结直肠癌中发挥肿瘤促进作用。
EBioMedicine. 2020 Jun;56:102800. doi: 10.1016/j.ebiom.2020.102800. Epub 2020 Jun 6.
8
Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.长链非编码 RNA H19 作为 miR-340-3p 的海绵体,通过调节紫杉醇耐药乳腺癌细胞中 YWHAZ 的表达促进上皮-间充质转化。
Environ Toxicol. 2020 Sep;35(9):1015-1028. doi: 10.1002/tox.22938. Epub 2020 May 18.
9
Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.人参皂苷 20(S)-Rg3 通过上调 HIF-1α 靶向 miR-519a-5p 抑制卵巢癌细胞的瓦博格效应。
Clin Exp Pharmacol Physiol. 2020 Aug;47(8):1455-1463. doi: 10.1111/1440-1681.13321. Epub 2020 May 4.
10
Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.基于网络分析的长链非编码 RNA 作为三阴性乳腺癌患者生存预测因子的鉴定。
Biomed Res Int. 2020 Mar 3;2020:8970340. doi: 10.1155/2020/8970340. eCollection 2020.